Elbrit Life Sciences
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimibrit MV 1mg/500mg/0.2mg Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glimibrit MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimibrit MV 1mg/500mg/0.2mg Tablet is to be taken empty stomach.
Glimibrit MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimibrit MV 1mg/500mg/0.2mg Tablet is a combination of three medicines: Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, improving blood glucose levels when taken with a proper diet and regular exercise. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production in the liver and improves insulin sensitivity, and Voglibose lowers postprandial glucose levels. This combination is not indicated for the treatment of Type 1 DM.
The use of Glimibrit MV 1mg/500mg/0.2mg Tablet may cause common side effects such as hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare professional for guidance.
Glimibrit MV 1mg/500mg/0.2mg Tablet should be avoided in patients with known allergy to any of its components or excipients. Additionally, it is contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis. Consult your doctor or healthcare professional before taking this medicine if you have any of these conditions.
No, it is not recommended to take Glimibrit MV 1mg/500mg/0.2mg Tablet with alcohol. This combination may increase the risk of hypoglycemia and lactic acidosis. It is essential to follow your doctor's or healthcare professional's advice on alcohol consumption while taking this medicine.
Yes, Glimibrit MV 1mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is crucial to monitor your blood sugar levels regularly and take necessary precautions to prevent hypoglycemia. If you experience any of these symptoms, consult your doctor or healthcare professional for guidance.
Store Glimibrit MV 1mg/500mg/0.2mg Tablet in its original packaging, tightly closed. Follow the storage instructions provided on the packaging or label. Dispose of any unused medicine properly, ensuring it is not consumed by pets, children, or other individuals.